Summary by Moomoo AI
CORNINGER PHARMACEUTICAL-B (ALPHAMAB-B) PUBLISHED ITS ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT FOR 2023 COVERING THE PERIOD FROM JANUARY 1 TO DECEMBER 31, 2023. The report shows that the company focuses on the discovery, development, production and commercialization of bio-innovative drugs in the anti-tumor field and listed on the main board of the Hong Kong Stock Exchange on 12 December 2019. The company strives to develop the next generation of innovative medicines, following the corporate philosophy of “Patients of Condé and the Home of Ruizei”. During the reporting period, the company actively promoted the construction of environmental management systems and made significant progress in environmental, social and governance. The company strictly adheres to relevant laws and regulations and communicates with employees in a variety...Show More